NY Times director granted 2,277 RSUs
Brooke Beth A. reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Brooke Beth A. reported acquisition or exercise transactions in this Form 4 filing.
NEW YORK TIMES CO director Beth A. Brooke received a grant of 2,277 Class A share equivalents as equity compensation. The award consists of stock-settled restricted stock units under The New York Times Company 2020 Incentive Compensation Plan, with no cash paid per unit.
Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock and will vest on the date of the following Annual Meeting of Stockholders. After this grant, Brooke directly holds 22,099 Class A shares, and vested shares from this award will be delivered within 90 days after her service on the Board of Directors ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 2,277 | $0.00 | $0.00 |
Footnotes (1)
- F1. Consists of a grant of stock-settled restricted stock units under The New York Times Company 2020 Incentive Compensation Plan. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock and vests on the date of the following Annual Meeting of Stockholders. Vested shares will be delivered within 90 days following the cessation of the reporting person's membership on the Board of Directors.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
2020 Incentive Compensation Plan financial
Annual Meeting of Stockholders financial
Board of Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did NYT director Beth A. Brooke report in this Form 4?
When do Beth A. Brooke’s newly granted NYT restricted stock units vest?
Are Beth A. Brooke’s NYT restricted stock units part of a company incentive plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.